Skip to main content
TipRanks
Go Ultimate75% OFF

Redcare Pharmacy (RDC) Stock Statistics & Valuation Metrics

79 Followers

Total Valuation

Redcare Pharmacy has a market cap or net worth of EUR 1.40B. The enterprise value is EUR 1.72B.

Market Cap
EUR 1.40B
Enterprise Value
EUR 1.72B

Share Statistics

Redcare Pharmacy has 20,578,390 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
20,578,390
Owned by Insiders
2.11%
Owned by Institutions
13.96%

Financial Efficiency

Redcare Pharmacy’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -2.11%.

Return on Equity (ROE)
-0.08
Return on Assets (ROA)
-0.03
Return on Invested Capital (ROIC)
-2.11%
Return on Capital Employed (ROCE)
-0.03
Revenue Per Employee
1.36M
Profits Per Employee
-17.43K
Employee Count
2,163
Asset Turnover
2.36
Inventory Turnover
10.97

Valuation Ratios

The current PE Ratio of Redcare Pharmacy is -40.26. Redcare Pharmacy’s PEG ratio is 16.82.

PE Ratio
-40.26
PS Ratio
0.41
PB Ratio
3.00
Price to FCF
-42.77
Price to Operating Cash Flow
31.97
PEG Ratio
16.82

Income Statement

In the last 12 months, Redcare Pharmacy had revenue of 2.94B and earned -37.70M in profits. Earnings per share was -1.87.

Revenue
2.94B
Gross Profit
593.70M
Operating Income
-23.80M
Pretax Income
-47.70M
Net Income
-37.70M
EBITDA
45.60M
Earnings Per Share (EPS)
-1.87

Cash Flow

In the last 12 months, operating cash flow was 42.96M and capital expenditures -75.06M, giving a free cash flow of -32.11M billion.

Operating Cash Flow
42.96M
Free Cash Flow
-32.11M
Free Cash Flow per Share
-1.59

Dividends & Yields

Redcare Pharmacy pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-2.34%
Earnings Yield
-2.48%

Stock Price Statistics

Beta
1.53
52-Week Price Change
9.85%
50-Day Moving Average
68.38
200-Day Moving Average
57.90
Relative Strength Index (RSI)
42.83
Average Volume (3m)
83.88K

Important Dates

Redcare Pharmacy upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 29, 2026
Next Earnings Date
Mar 03, 2027
Ex-Dividend Date
―

Financial Position

Redcare Pharmacy as a current ratio of 1.55, with Debt / Equity ratio of 90.51%

Current Ratio
1.55
Quick Ratio
1.01
Debt to Market Cap
0.27
Net Debt to EBITDA
7.09
Interest Coverage Ratio
-1.17

Taxes

In the past 12 months, Redcare Pharmacy has paid -8.30M in taxes.

Income Tax
-8.30M
Effective Tax Rate
0.17

Enterprise Valuation

Redcare Pharmacy EV to EBITDA ratio is 20.50, with an EV/FCF ratio of -51.02.

EV to Sales
0.49
EV to EBITDA
20.50
EV to Free Cash Flow
-51.02
EV to Operating Cash Flow
38.13

Balance Sheet

Redcare Pharmacy has EUR 132.40M in cash and marketable securities with EUR 354.50M in debt, giving a net cash position of -EUR 222.10M billion.

Cash & Marketable Securities
EUR 132.40M
Total Debt
EUR 354.50M
Net Cash
-EUR 222.10M
Net Cash Per Share
-EUR 10.79
Tangible Book Value Per Share
EUR 4.45

Margins

Gross margin is 20.26%, with operating margin of 0.11%, and net profit margin of -1.02%.

Gross Margin
20.26%
Operating Margin
0.11%
Pretax Margin
-0.93%
Net Profit Margin
-1.02%
EBITDA Margin
2.39%
EBIT Margin
0.16%

Analyst Forecast

The average price target for Redcare Pharmacy is EUR 94.57, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
EUR 94.57
Price Target Upside
38.97% Upside
Analyst Consensus
Strong Buy
Analyst Count
7
Revenue Growth Forecast
18.58%
EPS Growth Forecast
3.07%

Scores

Smart Score
8
AI Score
51